Discover how the ALA-CART platform enhances CAR T cell efficacy against antigen-low leukemias. With improved LAT activation, ...

Researchers at the University of Colorado Anschutz Medical Campus have successfully developed a supercharged iteration of CAR ...

Researchers have successfully developed a supercharged iteration of CAR-T cell therapy that can enhance the effectiveness and longevity of the cells, particularly against cancer cells that are harder ...

Prognosis after relapse is poor, with 5-year survival rates dropping to around 30%. CAR T-cell therapy is a personalised treatment where a patient’s T cells are extracted, genetically modified ...

An 18-year survivor of neuroblastoma, a solid childhood tumor that develops in immature nerve cells, is believed to represent the longest reported remission to date in a patient treated with chimeric ...

Time flies when you're driving. It's somehow already been a year since Pacific Drive launched and became my favorite survival game of 2024. And in those 12 months a whole lotta people have gotten ...

Yescarta – a CD19-directed genetically modified autologous T-cell immunotherapy investigated in the ZUMA-1 trial – is the first chimeric antigen receptor (CAR) T-cell therapy recommended for ...

If you’re a gearhead, there’s a good chance you’ve heard about the latest report from The Driveconcerning rumors about a sub-$30K entry-level performance car being floated from Dodge’s new ...

BROOK, Ind. (WLS/CNN/CNN Newsource/WKRC) - A woman survived six days trapped in a car after crashing into a creek in Indiana. Brianna Castle, 41, demonstrated remarkable resilience as she survived ...

A single molecular switch is essential for blood stem cells to enter an activated, regenerative state in which they produce new blood cells, according to a preclinical study led by Weill Cornell ...